SEARCH:   Advanced		CURRENT ISSUE+more issues CME Credit Now Available Monthly 29 Jul 2010 Treatment with intravenous melphalan and dexamethasone is not able to overcome the poor prognosis of patients with newly diagnosed systemic light chain amyloidosis and severe cardiac involvement Plasma levels of fibrinolytic proteins and the risk of myocardial infarction in men The effect of deferasirox on cardiac iron in thalassemia major: impact of total body iron stores Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia Successful engraftment after reduced-intensity umbilical cord blood transplantation for myelofibrosis e-LETTERS Most recent Similar results of clinical observation studies on deferasirox and cardiac iron in thalassemia major Longer half-life FVIII - not less often but less Early response to steroids in acute GvHD Monitoring low levels of MRD Read more How to submit an e-Letter ANNOUNCEMENTS Blood now offers faster feedback through e-Letters Hematologists Can Now Earn CME Credits through Blood Blood Cited as One of the Top 100 Influential Biology and Medicine Journals ASH’s Alternative to NIH Policy on Public Access THREE MOST FREQUENTLY READ ARTICLES+more collections WHO-EORTC classification for cutaneous lymphomas May 15, 2005 How I treat patients with diffuse large B-cell lymphoma Jul 01, 2007 How I treat idiopathic thrombocytopenic purpura (ITP) Oct 01, 2005